Document Detail


Using hyaluronic acid derivatives and cultured autologous fibroblasts and keratinocytes in a lower limb wound in a patient with diabetes: a case report.
MedLine Citation:
PMID:  12271733     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with diabetes have an impaired wound healing process that contributes to the pathophysiology that may lead to amputation. In this case study, an extensive (103.49 cm2) full-thickness cutaneous wound with exposure of a necrotic Achilles' tendon in a patient with diabetes, neuropathy, and infrapopliteal vascular disease of the lower limbs was healed using a two-stage autologous skin substitute technique. The scaffolds on which the autologous fibroblasts and keratinocytes were grown comprised an ester derivative of hyaluronic acid. Two applications of the cultured autologous fibroblasts and one of the cultured autologous keratinocytes were placed on the wound at 7-day intervals. The ulcer healed completely 60 days following the first fibroblast graft application. After 16 months of follow-up, no recurrence was noted and the patient can walk without ancillary support. This novel tissue engineering technique is a promising treatment for wound healing.
Authors:
Luca Dalla Paola; Alberto Cogo; Walter Deanesi; Cristina Stocchiero; Valerie Carmela Colletta
Related Documents :
6795703 - Inhibition of increased synthesis of glomerular basement membrane collagen in diabetic ...
21962873 - Discrete choice as a method for exploring education preferences in a danish population ...
2693143 - Blood pressure, proteinuria and their relationship with circulatory mortality: the who ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Ostomy/wound management     Volume:  48     ISSN:  0889-5899     ISO Abbreviation:  Ostomy Wound Manage     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-25     Completed Date:  2002-10-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8912029     Medline TA:  Ostomy Wound Manage     Country:  United States    
Other Details:
Languages:  eng     Pagination:  46-9     Citation Subset:  N    
Affiliation:
Diabetic Foot Unit, Department of Endocrinology and Metabolism, Villa Berica Hospital, Vicenza, Italy. ldallapaola@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Achilles Tendon / injuries*
Adjuvants, Immunologic / therapeutic use*
Aged
Cells, Cultured
Diabetic Neuropathies / physiopathology*
Fibroblasts*
Humans
Hyaluronic Acid / analogs & derivatives,  therapeutic use*
Keratinocytes*
Male
Treatment Outcome
Wound Healing / drug effects*
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preventing foot ulceration and amputation by decompressing peripheral nerves in patients with diabet...
Next Document:  Offloading diabetic foot wounds using the scotchcast boot: a retrospective study.